NeoGenomics, Inc. logo

NeoGenomics, Inc.

NASDAQ:NEO

Overview | Financials
Company Name NeoGenomics, Inc.
Symbol NEO
Currency USD
Price 10.23
Market Cap 1,314,156,030
Dividend Yield 0%
52-week-range 8.98 - 19.11
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Christopher Michael Smith BSc
Website https://www.neogenomics.com

An error occurred while fetching data.

About NeoGenomics, Inc.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and

Related Stocks

Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc.

LYEL

0.672 USD

LeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc.

LMAT

81.52 USD

Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc.

AXSM

119.45 USD

Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc.

ARQT

15.16 USD

Crinetics Pharmaceuticals, Inc. logo

Crinetics Pharmaceuticals, Inc.

CRNX

35.4 USD

Veru Inc. logo

Veru Inc.

VERU

0.492 USD

MannKind Corporation logo

MannKind Corporation

MNKD

5.21 USD

Financials

Numbers are in millions USD

Numbers are in millions USD